Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02407340 · ClinicalTrials.gov registry record · Phase 1
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT02407340: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT02407340 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02407340, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study will examine the utility of the neuropeptide oxytocin (OT) as a potential new medication for the treatment of Alcohol use disorder (AUD). Non-treatment seeking men and women with AUD will be enrolled in a double blind placebo controlled phase I clinical trial. Participants will complete an 7-day inpatient protocol. During the first 3 days of the inpatient protocol, participants will complete alcohol abstinence in which withdrawal symptoms are measured,and urine will be collected to determine withdrawal symptom severity and urine levels of the stress hormone cortisol. Participants will then complete 3 laboratory procedures which measure 1) stress response, 2) motivation to drink alcohol and 3) subjective and physiological effects of alcohol. Finally, because participants are individuals with AUD, investigators will administer a brief intervention to address their risky alcohol drinking and problems before discharge.
Interventions
- DRUG placebo
- DRUG oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-06-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02407340
The ClinicalTrials.gov registry entry for NCT02407340 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02407340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02407340 about?
NCT02407340 is a clinical study titled "Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder". This study will examine the utility of the neuropeptide oxytocin (OT) as a potential new medication for the treatment of Alcohol use disorder (AUD). Non-treatment seeking men and women with AUD will be enrolled in a double blind placebo controlled phase I clinical trial. Participants will complete a...
What is the current status of trial NCT02407340?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2015-03. Estimated completion is 2017-06-15.
What interventions are being tested in trial NCT02407340?
The interventions under investigation include: placebo (DRUG), oxytocin (DRUG).
Who is sponsoring clinical trial NCT02407340?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.